project id: TCGA-COAD; case submitter id: TCGA-D5-5539; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22097; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 22097; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 596.0; icd 10 code: C18.2; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ascending colon; synchronous malignancy: No; tissue or organ of origin: Ascending colon; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.5; longest dimension: 0.7; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-D5-5539-01A-01; percent lymphocyte infiltration: 11.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0;